The case for widespread use of sensor-data in healthcare
The science of using sensor data to define, measure, and create mathematical models of disease can lead to better outcomes—and huge benefits—for everyone in healthcare and life sciences.
The science of using sensor data to define, measure, and create mathematical models of disease can lead to better outcomes—and huge benefits—for everyone in healthcare and life sciences.
Fitbit is launching a trial to see if its its newest smartwatch could use pulse arrival time to measure blood pressure. Other wearable companies have tried to add wrist-based blood pressure features to their devices, but so far, they have limited accuracy.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Google announced it had closed its planned acquisition of Fitbit on Thursday, even thought the deal is still being investigated by the U.S. Department of Justice.
In this webinar on Feb. 10, healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors, represent a new standard of care in remote cardiac monitoring.
After European regulators signed off on the deal, Australian regulators rejected a proposal by Google to assuage concerns about its proposed acquisition of Fitbit. They will continue their investigation of the merger through the end of March.
Remote monitoring startup BioIntelliSense and Royal Phillips received $2.8 million to test BioIntelliSense’s device for the early detection of Covid-19 symptoms. The startup received FDA clearance for its small, adhesive monitoring device last year.
The virtual study, which included wearable data from more than 30,500 participants, found that changes in sleep, activity and heart rate levels, along with self-reported symptom data, could be used to identify potential cases of Covid-19.
After sharing early data from a study of its wearables’ ability to detect Covid-19 early, Fitbit plans to launch a prospective study with Northwell Health to see if its algorithm can detect illness before symptoms appear.
Before the pandemic started, the U.S. Department of Defense and Philips designed a system to detect potential infections before symptoms appear. Now, they’re turning it on the Covid-19 pandemic.
The University of California Irvine will conduct the virtual study, that was designed with Apple. It will look at how devices such as an Apple Watch or iPhone could be used to help patients with asthma self-manage their condition.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The wearables maker received 510(k) clearance for an electrocardiogram app used to assess heart rhythm for atrial fibrillation.
A survey of more than 7,000 consumers by Accenture found that they listed data privacy and efficacy as their top concerns with digital health tools and services. But the majority said they’d be willing to get virtual care from traditional healthcare providers.
Biofourmis, a Boston-based company that makes software-based therapeutic platforms, raised $100 million in a series C round led by SoftBank’s second Vision Fund. The company currently has developed a digital therapeutic for heart failure patients with Novartis, and plans to expand into other clinical areas.
The e-commerce giant made its debut in the wearables market with Halo, a fitness tracker with some unique features. Amazon said the device and its corresponding app can scan a user’s voice for emotions and measures a user’s body composition.
Fitbit’s new, $330 smartwatch has a slew of new features, including a wrist-based temperature sensor and a sensor to monitor stress.